Status of HPV vaccine introduction and barriers to country uptake.


Gallagher, KE; LaMontagne, DS; Watson-Jones, D; (2018) Status of HPV vaccine introduction and barriers to country uptake. Vaccine. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2018.02.003

[img]
Preview
Text - Published Version
License:

Download (839kB) | Preview

Abstract

During the last 12 years, over 80 countries have introduced national HPV vaccination programs. The majority of these countries are high or upper-middle income countries. The barriers to HPV vaccine introduction remain greatest in those countries with the highest burden of cervical cancer and the most need for vaccination. Innovation and global leadership is required to increase and sustain introductions in low income and lower-middle income countries.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
PubMed ID: 29580641
URI: http://researchonline.lshtm.ac.uk/id/eprint/4647187

Statistics


Download activity - last 12 months
Downloads since deposit
29Downloads
22Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item